Vimta Labs Limited
Vimta Labs Limited (VIMTALABS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Healthcare Research, Analytics & Technology
vimta.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Stock price
₹655.35
Market cap
2,928 Cr
Stock P/E
37.9
P/B
6.40
Dividend yield
0.2%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82 Cr | 83 Cr | 73 Cr | 82 Cr | 80 Cr | 82 Cr | 85 Cr | 90 Cr | 94 Cr | 98 Cr | 102 Cr | 99 Cr |
| Operating expenses (approx.) | 58 Cr | 59 Cr | 58 Cr | 60 Cr | 55 Cr | 57 Cr | 55 Cr | 57 Cr | 61 Cr | 64 Cr | 68 Cr | 64 Cr |
| EBITDA | 24 Cr | 25 Cr | 16 Cr | 22 Cr | 24 Cr | 25 Cr | 30 Cr | 33 Cr | 33 Cr | 34 Cr | 34 Cr | 34 Cr |
| OPM % | 29.5% | 29.5% | 21.6% | 26.7% | 30.6% | 30.0% | 35.3% | 36.8% | 35.0% | 34.5% | 33.6% | 34.7% |
| Other income | 0.67 Cr | 0.59 Cr | 2 Cr | 0.90 Cr | 0.49 Cr | 0.69 Cr | 0.68 Cr | 1 Cr | 2 Cr | 2 Cr | 3 Cr | 2 Cr |
| Interest | 0.25 Cr | 0.44 Cr | 0.61 Cr | 0.54 Cr | 0.53 Cr | 0.48 Cr | 0.41 Cr | 0.58 Cr | 0.44 Cr | 0.32 Cr | 0.37 Cr | 0.16 Cr |
| Depreciation | 8 Cr | 8 Cr | 9 Cr | 9 Cr | 8 Cr | 8 Cr | 8 Cr | 10 Cr | 9 Cr | 10 Cr | 10 Cr | 11 Cr |
| Profit before tax | 17 Cr | 16 Cr | 8 Cr | 14 Cr | 16 Cr | 17 Cr | 20 Cr | 29 Cr | 25 Cr | 25 Cr | 26 Cr | 23 Cr |
| Tax % | 23.4% | 25.2% | 24.6% | 25.0% | 24.2% | 25.7% | 24.3% | 22.2% | 26.8% | 25.2% | 24.2% | 24.8% |
| Net profit | 13 Cr | 12 Cr | 6 Cr | 10 Cr | 12 Cr | 12 Cr | 15 Cr | 21 Cr | 18 Cr | 19 Cr | 20 Cr | 18 Cr |
| EPS (₹) | ₹5.73 | ₹5.51 | ₹2.85 | ₹4.57 | ₹5.58 | ₹5.54 | ₹6.88 | ₹9.65 | ₹8.22 | ₹4.25 | ₹4.46 | ₹3.96 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 213 Cr | 181 Cr | 211 Cr | 278 Cr | 318 Cr | 318 Cr | 344 Cr | Sign in for TTM |
| Operating expenses (approx.) | 155 Cr | 151 Cr | 158 Cr | 198 Cr | 223 Cr | 231 Cr | 222 Cr | Sign in for TTM |
| EBITDA | 58 Cr | 30 Cr | 53 Cr | 80 Cr | 95 Cr | 87 Cr | 122 Cr | Sign in for TTM |
| OPM % | 27.1% | 16.6% | 25.1% | 28.9% | 29.8% | 27.3% | 35.5% | Sign in for TTM |
| Other income | 2 Cr | 3 Cr | 0.83 Cr | 1 Cr | 3 Cr | 4 Cr | 4 Cr | Sign in for TTM |
| Interest | 5 Cr | 4 Cr | 2 Cr | 1 Cr | 3 Cr | 2 Cr | 2 Cr | Sign in for TTM |
| Depreciation | 20 Cr | 21 Cr | 23 Cr | 23 Cr | 31 Cr | 34 Cr | 35 Cr | Sign in for TTM |
| Profit before tax | 35 Cr | 8 Cr | 29 Cr | 56 Cr | 65 Cr | 54 Cr | 90 Cr | Sign in for TTM |
| Tax % | 28.0% | 17.2% | 25.0% | 25.8% | 25.9% | 24.7% | 24.6% | Sign in for TTM |
| Net profit | 25 Cr | 7 Cr | 21 Cr | 41 Cr | 48 Cr | 41 Cr | 67 Cr | Sign in for TTM |
| EPS (₹) | ₹11.45 | ₹3.10 | ₹9.68 | ₹18.70 | ₹21.77 | ₹18.51 | ₹30.28 | Sign in for TTM |
| Dividend payout % | — | — | — | 10.7% | 9.2% | 10.8% | 6.6% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr |
| Reserves | 167 Cr | 168 Cr | 190 Cr | 230 Cr | 277 Cr | 315 Cr | 374 Cr |
| Borrowings | — | 23 Cr | 23 Cr | 19 Cr | 15 Cr | 19 Cr | 9 Cr |
| Other liabilities | — | 50 Cr | 57 Cr | 54 Cr | 66 Cr | 61 Cr | 79 Cr |
| Total liabilities | — | 246 Cr | 274 Cr | 307 Cr | 362 Cr | 400 Cr | 467 Cr |
| Fixed assets (net) | — | 132 Cr | 129 Cr | 150 Cr | 157 Cr | 156 Cr | 224 Cr |
| CWIP | — | 2 Cr | 17 Cr | 0.31 Cr | 12 Cr | 59 Cr | 38 Cr |
| Investments | — | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Loans & advances | — | 1 Cr | 1 Cr | 0.10 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr |
| Inventories | — | 17 Cr | 15 Cr | 17 Cr | 23 Cr | 25 Cr | 25 Cr |
| Trade receivables | — | 58 Cr | 73 Cr | 77 Cr | 80 Cr | 87 Cr | 106 Cr |
| Cash & bank | — | 6 Cr | 6 Cr | 11 Cr | 31 Cr | 13 Cr | 16 Cr |
| Other assets | — | 30 Cr | 32 Cr | 52 Cr | 60 Cr | 60 Cr | 58 Cr |
| Total assets | — | 246 Cr | 274 Cr | 307 Cr | 362 Cr | 400 Cr | 467 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 59 Cr | 88 Cr | 61 Cr | 95 Cr |
| Cash from investing | — | — | — | -38 Cr | -57 Cr | -76 Cr | -76 Cr |
| Cash from financing | — | — | — | -17 Cr | -11 Cr | -2 Cr | -17 Cr |
| Net cash flow | — | — | — | 5 Cr | 20 Cr | -17 Cr | 2 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 20 Cr | 38 Cr | -16 Cr | 15 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| ROCE % | 23.2% | 7.0% | 15.8% | 24.4% | 22.8% | 16.7% | 23.8% |
| ROE % | 0.0% | 4.0% | 11.0% | 0.0% | 0.0% | 0.0% | 17.8% |
| Debtor days | — | 117 | 127 | 101 | 92 | 100 | 112 |
| Inventory days | — | 117 | 92 | 80 | 112 | 118 | 128 |
| Days payable | — | 72 | 93 | 57 | 71 | 39 | 53 |
| Cash conversion cycle | — | 162 | 126 | 124 | 132 | 179 | 187 |
| Debt / equity | — | 0.13 | 0.12 | 0.08 | 0.05 | 0.06 | 0.02 |
| Current ratio | — | 1.67 | 2.05 | 2.60 | 2.86 | 2.91 | 2.92 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -0.16 | 0.07 | -0.06 |
Compare with peers
Loading peers…